Myelofibrosis

Latest News

Image Credit: © Formoney - stock.adobe.com

Decadine Demonstrates Therapeutic Potential for the Treatment of Myelofibrosis

By Alexandra Gerlach, Associate Editor

October 2nd 2024

The findings may offer patients treatment options beyond symptom palliation.

Researchers Identify INCA033989 as a Potential Treatment for Myeloproliferative Neoplasms

By Alexandra Gerlach, Associate Editor

September 26th 2024

INCA033989 is a monoclonal antibody that selectively targets mutant calreticulin oncogenic function.

Image Credit: © Ployker - stock.adobe.com

Study Finds Ruxolitinib May Slow Fibrosis Progression in Myelofibrosis

By Alexandra Gerlach, Associate Editor

September 24th 2024

Researchers found that PF4/Cxcl4, a key driver of fibrosis, was up regulated on all proteomes.

Image Credit: © Sittipol - stock.adobe.com

Study Demonstrates Safety, Efficacy of Luspatercept for MF-Related Anemia

By Alexandra Gerlach, Associate Editor

September 19th 2024

Luspatercept reduced the need for transfusion in patients with myelofibrosis (MF).

Myelofibrosis -- Image credit: shidlovski | stock.adobe.com

Disease- and Patient-Related Factors Guide Decisions For Patients With Myelofibrosis Receiving allo-HCT

By Gillian McGovern, Assistant Editor

September 6th 2024

Disease-related factors include several prognostic scoring systems, such as DIPSS, whereas patient-related factors involve age, comorbidities, spleen size, and anemia.

<1 2

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777